Great success in the Shanghai ranking: reputation of the divisional university strengthened.

A European consortium with the participation of the MHH is developing a new tool to determine the individual risk of liver fibrosis and liver cancer.

Vascular prostheses made from the blood protein fibrin: The biocompatible alternative to synthetic plastic prostheses is now to be made increasingly…

MHH molecular physician Professor Dr. Dr. Schambach wants to find new therapeutic options against three particularly malignant cancers.

In MS, misdirected immune cells damage the sheaths of the nerve cells in the brain. Researchers at the MHH have discovered a repair mechanism.

Garbers would like to network the previous research foci of glycobiochemistry and diabetology more closely together with cytokine research.

Dr. Alice Rovai receives the publication award of the German Liver Foundation.

Disturbed dream sleep may indicate later Parkinson's disease.

The ATMP-GMPDU development unit at the Institute for Cell Therapeutics supports research groups in the development of new cellular drugs.

A clinical trial under MHH leadership is testing a new therapy with immune cells against the JC virus.